Recruiting Pulmonary Hypertension Studies in Carmel
Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.
The aim of the study is to compare the safety and efficacy of two doses of Nexium in maintaining healing of erosive esophagitis in patients 1 to 11 years of age....
A Study Assessing KB801 for the Treatment of Stage 2 or 3 Neurotrophic Keratitis
The Sponsor is developing KB801, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector engineered to deliver functional full-length human nerve growth factor (NGF...
About Pulmonary Hypertension Clinical Trials in Carmel
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 2 pulmonary hypertension clinical trials recruiting participants in Carmel, INDIANA. These studies are seeking a combined 77 participants. Research is being sponsored by AstraZeneca, Krystal Biotech, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Carmel — FAQ
Are there pulmonary hypertension clinical trials in Carmel?
Yes, there are 2 pulmonary hypertension clinical trials currently recruiting in Carmel, INDIANA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Carmel?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Carmel research site will contact you about next steps.
Are clinical trials in Carmel free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Carmel studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 2 active trials in Carmel are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov